Advanced and cellular therapies are the future of medicine. The reason? They are highly innovative treatments based on the use of genes (gene therapy), cells (cell therapy), or tissues (tissue engineering) to prevent or treat various diseases. They result from years of research and technological advances that aim to generate personalized treatments, establishing a true revolution in biomedicine and offering an answer to complex diseases that until now have no effective treatments or conventional therapies that have dangerous side effects.

IMPACT is focused on improving people’s health and quality of life by directing all its efforts and capabilities to make new advanced therapies accessible to the general public. To achieve this, we seek to bridge the gap between scientific research and clinical practice to produce precision and advanced therapies that are accessible, affordable, and simple.

IMPACT’s work initially focuses on four areas of biomedicine related to diseases such as cancer, musculoskeletal diseases, mental health, and perinatal diseases or pregnancy complications.

We have collaborated with national higher education centers of great prestige, such as the Catholic University of Valparaiso through the School of Biochemical Engineering, the Pontificia Universidad Católica de Chile through the School of Electrical Engineering and the Department of Biological and Medical Engineering, and finally the University of Chile through the Departments of Electrical Energy and Chemical Engineering, Biotechnology and Materials. In addition, IMPACT is the collaboration of prestigious international institutions, generating a network that promotes and encourages scientific excellence.